Viking Therapeutics (VKTX) Leases: 2019-2025
Historic Leases for Viking Therapeutics (VKTX) over the last 7 years, with Sep 2025 value amounting to $666,000.
- Viking Therapeutics' Leases fell 40.16% to $666,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $666,000, marking a year-over-year decrease of 40.16%. This contributed to the annual value of $1.0 million for FY2024, which is 10.92% down from last year.
- Latest data reveals that Viking Therapeutics reported Leases of $666,000 as of Q3 2025, which was down 14.62% from $780,000 recorded in Q2 2025.
- Viking Therapeutics' 5-year Leases high stood at $1.6 million for Q1 2022, and its period low was $25,000 during Q4 2021.
- Over the past 3 years, Viking Therapeutics' median Leases value was $1.1 million (recorded in 2024), while the average stood at $1.0 million.
- In the last 5 years, Viking Therapeutics' Leases crashed by 92.21% in 2021 and then skyrocketed by 5,572.00% in 2022.
- Quarterly analysis of 5 years shows Viking Therapeutics' Leases stood at $25,000 in 2021, then skyrocketed by 5,572.00% to $1.4 million in 2022, then declined by 20.59% to $1.1 million in 2023, then decreased by 10.92% to $1.0 million in 2024, then tumbled by 40.16% to $666,000 in 2025.
- Its Leases stands at $666,000 for Q3 2025, versus $780,000 for Q2 2025 and $892,000 for Q1 2025.